In the present paper, hydrogels based on acrylic acid (20%), sodium alginate (0.5%) and poly(ethylene oxide) (0.1%) were obtained by electron beam irradiation at room temperature with doses between 5 and 20 kGy, using potassium persulfate in concentrations up to 0.3% as a reaction initiator. The influence of initiator concentration and irradiation dose on hydrogel network parameters, swelling and deswelling behavior, gelation and degradation points, structure and morphology were investigated. Cross-link density increased with the irradiation dose and initiator addition, except at 20 kGy. The gel fraction was over 87.0% in all cases. Swelling experiments in distilled water showed swelling degrees of 40,000% at an irradiation dose of 5 kGy when a concentration of 0.1% initiator was added. A relationship between the swelling degree and irradiation dose, cross-linking degree (that increases from 0.044 × 10 to 0.995 × 10 mol/cm) and mesh size (that decreases from about 220 nm to 26 nm) was observed. The addition of only 0.1% of PP led to the obtaining of hydrogels with a swelling degree of 42,954% (about 430 g/g) at an irradiation dose of 5 kGy and of 7206% (about 62 g/g) at 20 kGy, which are higher percentages than those obtained in the same irradiation conditions but without PP.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342547 | PMC |
http://dx.doi.org/10.3390/ma16134552 | DOI Listing |
Curr Oncol Rep
January 2025
Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA.
Purpose: To review recent advances with radiation therapy (RT) for soft tissue sarcomas (STS).
Recent Findings: Newer data showcases hypofractionated preoperative RT for soft tissue sarcomas treated with surgery to be safe and effective, however, long-term follow up data is pending. Hypofractionated and dose-escalated RT in patients with unresectable STS is also being studied, for which we remain optimistic given advances in RT planning approaches.
Int J Part Ther
March 2025
Department of Heavy Particle Medical Science, Yamagata University Graduate School of Medical Science, Yamagata, Japan.
Purpose: The study's purpose was to use a simple geometry phantom to validate the deformable image registration (DIR) accuracy and dose warping accuracy in carbon ion radiotherapy (CIRT) and to provide an index for dosimetry in CIRT.
Materials And Methods: We used geometric and anatomical phantoms provided by AAPM TG-132. The DIRs of 3 different settings were performed between reference and translational images for each phantom.
Indian J Clin Biochem
January 2025
Department of Biochemistry, College of Medicine and J.N.M Hospital, WBUHS, Kalyani, West Bengal 741235 India.
Radiation therapy uses ionizing radiation (IR) to kill cancer cells. However, during radiotherapy normal cells are also damaged and killed by the generation of reactive oxygen species. Polyphenolic compounds are known to mitigate the damaging effects of radiation.
View Article and Find Full Text PDFCureus
December 2024
Medical Affairs, Zydus Lifesciences, Ahmedabad, IND.
Background Human epidermal growth factor receptor 2 (HER2)-positive breast cancer is a highly aggressive subtype characterized by a high recurrence rate. Trastuzumab emtansine (T-DM1), an antibody-drug conjugate targeting HER2, has shown improved outcomes; however, its effectiveness in cases with brain metastases remains unclear. The T-DM1 biosimilar has emerged as a cost-effective treatment option.
View Article and Find Full Text PDFCancer Biol Ther
December 2025
Department of Radiotherapy, The First Affiliated Hospital of Soochow University, Suzhou, China.
Background And Purpose: Bone metastasis is common for breast cancer and associated with poor prognosis. Currently, radiotherapy (RT) serves as the standard treatment for patients exhibiting symptoms of bone metastasis to alleviate pain. Whether earlier application of RT will better control bone metastasis remains unclear.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!